QVT Financial

QVT Financial

Pulse 2.0

Concert Pharmaceuticals (CNCE) Stock Price: Why It Increased 6.05% Today

Pulse 2.0

Concert Pharmaceuticals (CNCE) Stock: Why The Price Surged Today


Global Superoxide Dismutase Cu-Zn Market 2020 – AveXis Inc , Ionis Pharmaceuticals Inc …

$80,000,000 Venture capital (Series A)

Kriya Therapeutics Raises $80M in Series A Financing

the home of AI info

Global Superoxide Dismutase [Cu-Zn] Market 2016-2026 | AveXis Inc, Ionis Pharmaceuticals Inc ...


SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow

Health Science
Bloomberg , Xconomy

Novartis to Buy AveXis in $8.7 Billion Gene-Therapy Deal

$30,000,000 Post-IPO debt
businesswire , PE HUB

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital


Dell Buys Exanet

$10,000,000 Venture capital (Series C)
VentureWire , FinSMEs

Gene Therapy Company AveXis Closes $10M Series C

$48,500,000 Venture capital (Series B)
Added by
via PE Hub

Concert Pharma Raises $48.5 Million